Authors:
TENERO DM
MARTIN DE
MILLER AK
ILSON B
BOIKE SC
ZARIFFA N
JORKASKY DK
Citation: Dm. Tenero et al., EFFECT OF AGE AND GENDER ON THE PHARMACOKINETICS OF EPROSARTAN, British journal of clinical pharmacology, 46(3), 1998, pp. 267-270
Authors:
FREED MI
MILLER AK
INGLIS AM
THOMPSON KA
LADLEY D
JORKASKY DK
Citation: Mi. Freed et al., ROSIGLITAZONE, A PPAR-GAMMA AGONIST, DOES NOT ALTER THE PHARMACOKINETICS OF NIFEDIPINE, A CYTOCHROME-P450 3A4-SUBSTRATE, Diabetes, 47, 1998, pp. 368-368
Authors:
INGLIS AML
MILLER AK
THOMPSON KA
JORKASKY DK
FREED MI
Citation: Aml. Inglis et al., COADMINISTRATION OF ROSIGLITAZONE AND ACARBOSE (A) - LACK OF A CLINICALLY RELEVANT PHARMACOKINETIC DRUG-INTERACTION, Diabetes, 47, 1998, pp. 1366-1366
Citation: Y. Gertner et Ak. Miller, DIE-LESS FORMING OF LARGE AND VARIABLE-RADII OF CURVATURE IN CONTINUOUS-FIBER THERMOPLASTIC-MATRIX COMPOSITE-MATERIALS, Journal of thermoplastic composite materials, 9(2), 1996, pp. 151-182
Citation: Sh. Zhao et al., SYNTHESIS OF ARYLPIPERAZINES VIA PALLADIUM-CATALYZED AROMATIC AMINATION REACTION WITH UNPROTECTED PIPERAZINES, Tetrahedron letters, 37(26), 1996, pp. 4463-4466
Authors:
THOMPSON KA
EVERITT DE
CHAPELSKY M
MILLER AK
HERZYK DJ
JORKASKY D
Citation: Ka. Thompson et al., SAFETY, PHARMACOKINETICS AND ANTIGENICITY OF SINGLE AND REPEAT IM INJECTIONS OF A RESHAPED HUMAN MONOCLONAL-ANTIBODY (RSHZ19) IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 61-61
Citation: Sb. Lee et Ak. Miller, A PHENOMENOLOGICAL MODEL FOR INTERGRANULAR FAILURE BY R-TYPE AND WEDGE-TYPE CAVITATION, Journal of engineering materials and technology, 117(3), 1995, pp. 311-321
Citation: K. Ramani et al., DIE-LESS FORMING OF THERMOPLASTIC-MATRIX CONTINUOUS FIBER-COMPOSITE MATERIALS - PROCESS AND DEMONSTRATION, Journal of engineering for industry, 117(4), 1995, pp. 501-507